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Summary.-With progressive growth ofsyngeneic sarcomata in rats there was a rise
in serum levels of lysozyme which correlated with their immunogenicity and their
macrophage content. By an examination of lymph/blood differences in normal and
in tumour bearing rats and of the production of lysozyme bycells obtained from the
tumours and maintained in vitro, it is apparent that the macrophages resident in a
tumour mass make a massive contribution to the elevation in serum lysozyme
concentrations. Tumour cells did not release detectable lysozyme activity. Tumour
amputation led to a rapid fall in lysozyme levels. Irradiation of the host rats abol-
ished the lysozyme response and the subsequent development of metastases in these
rats was associated with a rise in serum lysozyme. The serum concentration of this
enzyme reflects the macrophage content of a tumour mass and the draining lymph
nodes. We conclude that under well defined conditions serum lysozyme activity
may be a useful marker of macrophage mediated host responses to a tumour.
LARGE numbers ofmacrophages can be
found infiltrating some experimental
tumours (Evans, 1972) and the extent of
this macrophage infiltration appears to
reflect host resistance to the tumours
(Eccles and Alexander, 1974). We there-
fore set out to find a serum marker for
macrophages. We were seeking a macro-
phage product which appears in the
extracellular fluid and which could be
used to assess and perhaps monitor
macrophage mediated host response to
tumours. One possible product, synthe-
sized and released by macrophages, is
lysozyme.
Lysozyme (mucopeptide N-acetyl
muramyl hydrolase E.C.3.2.1.17), a stable
bacteriolytic enzyme described byFleming
(1922) is present in the tissue fluids of
many species (including the turnip).
There exists an extensive literature des-
cribing the levels of this enzyme in serum,
urine and tissues ofman and other animals
in a variety ofnormal and diseased states
(Moore and Osserman, 1974). Increased
levels of lysozyme are found in the serum
in those diseases characterized by granu-
loma formation, such as tuberculosis,
sarcoidosis and Crohn's disease, and very
high levels can also be found in the serum
and urine of patients with myelomono-
cytic and monocytic leukaemia (Osserman
and Lawlor, 1966). The major cell types
responsible for the synthesis and release of
lysozyme are ofthe monocyte-macrophage
series although it can also be found in the
lysosomes ofgranulocytes from which it is
released when the cells degranulate (Mc-
Clelland and van Furth, 1975).
Cappuccino and his colleagues (Cappu-
ccino, Winston and Perri, 1974) have
shown that inoculation of mice with BCG,
Zymosan or endotoxin causes a rise in
tissue levels oflysozyme and that this rise
seems to parallel the stimulatory effect of
these agents upon the reticuloendothelial
system. The rate ofrelease oflysozyme by
macrophages appears to be unaffected by
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their state of activation (Gordon, Todd
and Cohn, 1974). This finding indicates
that the levels of lysozyme in tissue fluids
may, under well defined conditions, reflect
the number of functioning macrophages
in an animal.
We therefore examined a series of rat
sarcomata to determine whether the levels
of lysozyme in the hosts' sera reflect the
macrophage response to the tumours and
whether it can be used as an index of
macrophage mediated host response.
MATERIALS AND METHODS
Lysozyme estimation.-The method em-
ployed for the quantitative estimation of
lysozyme was the "lysoplate" technique
described by Osserman and Lawlor (1966).
Briefly, this involves the diffusion of a 20,ul
aliquot of the test sample into a 1% agarose
gel containing u.v. killed Micrococcus lyso-
deikticus. The diameter of the area of
bacteriolysis developing after 18 h at room
temperature was scored by photographing
the plate on a special optical bench under
standard conditions and the diameters of
lysis were then measured to 0.1 mm on a
photographic print using vernier calipers. A
batch of normal serum from the same rat
strain (i.e. Hooded or August) as the test
samples was employed in serial dilution as a
standard for calibrating each plate.
Each batch ofnormal standard serum was
calibrated against purified hen's egg white
lysozyme using the method ofLitwack (1955).
Egg white lysozyme couldnot be used directly
as a standard inthe lysoplate method since its
diffusion characteristics in the gel were quite
different from those of the mammalian
enzymes. Furthermore, human and rat
lysozymes also differ markedly in their
behaviour inthegel. There was, however, no
significant difference between Hooded and
August rat serum lysozymes. The results
are expressed as tLg of egg white lysozyme
equivalent/ml.
Tumours.-The rat tumours employed
were chemically induced fibrosarcomata syn-
geneic in Hooded rats. They were all im-
planted intramuscularly in the right hind
limb of 8-12 week old rats ofthe appropriate
sex using 02 ml of a mechanically prepared
cell suspension. Details of the tumours
employed are shown in Table 1. Other
methods and experimental details are de-
scribed with the individual experiments
below.
RESULTS
Effect of tumour inoculation, growth and
surgical removal on serum lysozyme levels
Repeated examinations of aliquots of
thesameserum samplerevealedgoodrepro-
ducibility. The mean lysozyme level in
20 normal Hooded male rats was 6-6± 1-2
1ag/ml.
Frequent serum samples were obtained
from rats bearing the HSBPA, HSN and
MC3 tumours and assayed for lysozyme.
As can be seen from the diagram (Fig. 1),
there was a significant and progressive rise
in lysozyme levels in rats bearing the
HSBPA tumour but those bearing the
MC3 showed a much smaller rise which
was not progressive. Rats bearing the
HSN sarcoma showed a rise in serum
activity which was intermediate between
the results obtained from the HSPBA and
those from the MC3. Amputation of the
tumour bearing limb of rats bearing each
ofthe sarcomata was performed at Day 13
of tumour growth and led to a rapid
decline in serum lysozyme back to normal
levels. The HSBPA is a highly im-
munogenic tumour which rarely metas-
tasizes and contains large numbers of
macrophages (See Table 1). The HSN
TABLE I.-Details of the Tumours Employed in this Study
Rat strain and sex Tumour Carcinogen Immunogenicity
Hooded male HSBPA 3-4 Benzpyrene ++ +
Hooded female HSN 3-4 Benzpyrene + +
Hooded male MC3 20-Methylcholanthrene
* Assayed on Day 13 tumour mass as described by Evans (1972).
Metastatic Macrophage
capacity content (%)*
+ 42-63
+ 34-44
+++ 2-12
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FIG. 1. Serial serum lysozyme levels in syngeneic rats bearing the HSBPA (0), HSN (0) or MC3
(A) sarcomata. Amputation of the tumour bearing limb was performed at Day 13 in half the
rats and the post-amputation lysozyme levels are shown as dotted lines.
is less immunogenic, contains fewer macro-
phages and shows occasional metastases.
However, the MC3 sarcoma is by conven-
tional criteria non-immunogenic, con-
tains few macrophages and almost invaria-
bly gives rise to disseminated disease.
Macrophage content was assayed by the
methods described by Evans (1972).
Effect of growing tumours in irradiated rats
Hooded ratswereexposed towholebody
x-irradiation given in 3 doses of 300 rad at
Days 5, +1 and +7 where Day 0 was
the day oftumour inoculation. Following
inoculation of the HSBPA tumour serial
sera were collected and assayed. As can
be seen from the diagram (Fig. 2), irradia-
tion of the host rats abolished the rise in
lysozyme levels. It also caused a drama-
tic reduction in the macrophage content of
the tumour. Furthermore, examination
of serum lysozyme in rats irradiated but
not injected with tumour showed a fall in
activity reaching a nadir at 6-7 days after
the final 300 R. The tumours developing
in the irradiated rats grew at the same
rate as and reached the same diameter as
those grown in normal animals.
Serum lysozyme levels after tumour ampu-
tation.
The HSBPA sarcoma when grown
in normal syngeneic rats rarely gives rise
to metastases. Following amputation of
the tumour bearing limb of rats carrying
the HSBPA performed 13 days after
tumour inoculation, serial serum samples
were obtained. None of these rats died
or showed any evidence of metastatic
disease when followed for 56 days after
the amputation. The sequential serum
lysozyme levels of individual rats are
shown in Fig. 3 and show no significant
changes in enzyme activity.
However, when the HSBPA was
grown in rats irradiated as above and
then the tumour amputated at Day 13,
subsequent death from widespread metas-
tatic disease occurred rapidly. Sequential
serum samples from these rats showed a
rise in lysozyme concentrations which was
soon followed by death of the animals
from extensive metastatic disease. When
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FIG. 2.-Serum lysozyme levels in rats bearing the HSBPA sarcoma 0 O in intact rats,
O --- 0 in rats exposed to whole body irradiation. The figures at Day 13 show the percentage
of macrophages in the tumour mass on that day.
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FIG. 3.-Serum lysozyme levels in rats following amputation of the HSBPA sarcoma. Intact rats
(0 * 0) and rats which had received whole body irradiation (O
- -- 0). A rise in lysozyme
levels was associated with early death from metastases.
individual metastases from such rats were
examined for macrophage content it was
found that approximately 30% ofthe cells
in the lesions were macrophages.
Levels of lysozyme in serum and lymph of
tumour bearing rats.
Tumourbearing female Hooded ratsin-
oculated with HSN tumour 15 days previ-
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TABLE II.-Serum and Lymph Lysozyme
Activity in Normal and Tumour Bearing
Rats
Serum (ug/ml) Lymph (jsg/ml)
Normal rats 9 0 9-8
Tumour bearing
rats (HSN Day 15) 13-2 19-0
TABLE III.-Correlation of Serum Lyso-
zyme Activity and Macrophage Content of
the Tumours at Day 13
Tumour
HSBPA
MC3
HSN
HSBPA in
irradiated
rats
Macrophage
content (%)
47
8
32
12
Serum lysozyrne
(Yg/ml)
33
12-4
14-4
7-4
ously were anaesthetized with ether and
their thoracic ducts cannulated. Lymph
was collected from these rats and from
normalratsfor aperiodof2h, atwhichtime
they were bled by cardiac puncture. The
lymphandbloodwereallowedtoclotandthe
sera assayed forlysozyme. As can be seen
from Table II the lysozyme concentration
in normal rats was similar in blood and
lymph showing an even partition between
body fluid compartments to be expected
with such a low molecular weight material.
However, in the tumour bearing rats, in
the presence of elevated lysozyme levels
in the blood there was an even greater
concentration in the lymph. The thoracic
duct lymph obtained from these rats
drains primarily from the hind legs, the
site of the actively growing HSN tumour,
suggesting that large amounts oflysozyme
may be released from the tumour mass.
Correlation of serum lysozyme with macro-
phage content of tumours.
Estimations of the macrophage content
of tumours excised at Day 13 were made
by the method described by Evans (1972).
Table III indicates that there is a close
correlation between macrophage content
andthe level of lysozyme in the sera, with
one possible exception. In irradiated rats
bearing the HSBPA tumour there was a
lower serum lysozyme level than would
perhaps be indicated by the macrophage
content. This canbeexplainedbythefact
thatirradiationper se caused a fall in lyso-
zyme levels in tumour-free rats. Irradia-
tion of cultured macrophages with 100 rad
caused a significant reduction oftheir rate
oflysozyme release. The effect ofirradia-
tion on the macrophages and their entry
into a tumour could be due to many effects.
Immunosuppression as suggested by
Eccles and Alexander (1974), a direct
effect on bone marrow production of
monocytes or a direct effect on the macro-
phages could each be incriminated. The
present evidence does not resolve this
problem.
Production of lysozyme by cells in vitro
Tumour macrophages.-A Day 15 HSN
tumour was disaggregated with trypsin
and collagenase and the resulting cell sus-
pension added in serum-free medium in
aliquots of 20,u containing 5x104 cells
to the wells of lysozyme assay plates.
The plates were incubated at 37°C in 5%
CO2 for 18 h. This cell suspension pro-
duced large zones of bacteriolysis, indicat-
ing that lysozyme was being released.
Aliquots of the same suspension were also
incubated in plastic culture flasks for
2 h and then gently trypsinized (0-1%
trypsin for 10 min). The remaining
adherent cells were then cultured for a
further 24 h. The medium was then
collected, filtered through an 0-22 ,um
Millipore filter and assayed for lysozyme.
The number of cells in the culture was
then estimated by treatment with 6%
citric acid in 1: 2000 toluidine blue and
counting the resultant suspension of
stained nuclei. The lysozyme was ex-
pressed as jtg/106 cells. The adherent
cells, morphologically all macrophages,
released 7-2 ,ug lysozyme/106 cells/day.
Tumour cells.-The cells removed from
this first flask by the trypsinization were
placed in fresh flasks and the experiment
repeated on these subcultured cells. No
detectable lysozyme appeared in the
supernatant medium. Media from sub-
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cultured HSBPA, HSN and MC3 cells
were repeatedly assayed for lysozyme
and none was detected. We therefore
conclude that the lysozyme released from
the initial cell suspension obtained from
the tumour was produced by the tumour
macrophages.
Normal peritoneal exudate macrophages
The supernatant media from normal
peritoneal exudate macrophage cultures
(from normal Hooded rats) were examined
in a similar manner and were found to
release from 5K1 to 6-8 ,tg lysozyme/106
cells/day.
These findings indicate that the macro-
phages resident in a tumour are responsible
for the production of large quantities of
lysozyme. Simple calculations, employ-
ing an estimation of the number of cells in
a tumour, the percentage of macrophages,
rate of lysozyme production by macro-
phages iv vitro and the level of lysozyme
in the thoracic duct lymph indicate that
an HSN tumour 2 cm across may release
up to 100 mg of lysozyme a day. In that
the highest blood level of lysozyme in
-HSN tumour bearing animals rarely rises
above 15 ,ug/ml, we are forced to conclude
that the lysozyme released from tumour
macrophages must have a very short in
vivo half-life. This is supported by the
observation of the lymph/serum differ-
ences in lysozyme concentration seen in
tumour bearing rats and by the observa-
tions of Hansen and his colleagues
(Hansen, Karle and Andersen, 1974).
Normal Hooded rat peritoneal exudate
macrophages were also exposed to 10 jug/
ml of Salmonella typhosa lipopolysac-
charide B (Difco) and the release of
lysozyme followed for 3 days. No signifi-
cant change in the rate of lysozyme
release was detectable, a finding which
supports the observations of Gordon and
his colleagues (Gordon et al., 1972).
Lysozyme release by lymph node macro-
phages
The major lymphatic drainage of
tumours growing intramuscularly in the
thigh region of Hooded rats is to the para-
aortic nodes. These nodes were excised
from normal rats and from those bearing
the HSN sarcoma at 5, 12 and 19 days
after inoculation. The lymph nodes were
disrupted mechanically, the resulting cell
suspension was washed thrice and then
suspended in medium at 4 x 106/ml. Ali-
quots of these cell suspensions (20 ,ul)
were then added to wells oflysozyme assay
plates, together with a standard series of
dilutions of Hooded rat serum, and the
total release of lysozyme was measured
over 18 h. Samples of the lymph node
cell suspensions were also treated with
carbonyl iron (10 mg/ml) for 30 min on a
rotary mixer at 37°C and by subsequent
exposure to a powerful magnet. Aliquots
of the cell suspensions were also added to
the wells of 3040 (Falcoin) micro test
plates, incubated for 2 h and then vigor-
ously washed, fixed and stained with
Giemsa. The number of adherent cells
was counted and expressed as a percentage
of the total number added.
The results are shown in Table IV an(-d
demonstrate that normal unstimulated
nodes contain few cells which were
adherent or which released lysozyme.
TABLE IV. Release of Lysozyme by Cells
from Regional Lymph Nodes draining an
HSN Tumour
Lysozyme in
Time supernatant
(Days) medium (,ug/ml)
0} <0-,25
5 3-7
12 5a0
19 8-7
N.T., not tested.
After Percent
carbonyl iron adherent
(treatment ,ug/ml) cells
<0-25 <3
N.T. 7
N.T. 16
< 0-25 32
However, there was a progressive increase
in the percentage ofsuch cells with growth
of the HSN sarcoma. The adherent
lysozyme producing cells were removed
by the carbonyl-iron treatment. This
finding indicates that the lymph nodes
draining a tumour may also entrap large
numbers of macrophages in a manner
similar to the tumour mass itself.
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Ftc(.. 4. Effect of single intraperitoneal injections of BCG (0 0) or Corynebacterium parvum
(O - - -0) on serial serum lysozyme levels in male Hooded rats.
Effect of injection of BCG or Coryne-
bacterium parvum
Adult Hooded rats were given a single
intraperitoneal injection of 1 mg BCG
(Glaxo percutaneous) vaccine or 0 2 ml
of Corynebacterium parvum (Burroughs
Wellcome, Batch EZ 174) and serial
samples of sera obtained for a period
of 3 weeks. As can be seen from the
diagram shown in Fig. 4, both these agents
induced a rapid rise in serum lysozyme
concentration which reached a peak (10
days for BCG, 16 days for C. parvum) and
then declined. In the case of C. parvum
the rise was more rapid, the serum level
increasing four-fold within 4 days. This
early peak in activity may be due to a
polymorphonuclear cell response to the
injection of this killed organism, such a
response being less marked following the
injection of BCG. However, we suggest
that the sustained rise in lysozyme
induced by these agents is a reflection of
a considerable increase in the total number
of macrophages in the animals and is
probably not related to their state of
activation.
DISCUSSION
In rats bearing immunogenic syngeneic
fibrosarcomata there is an increase in
serum lysozyme activity which appears to
parallel tumour growth. There is a close
correlation between the lysozyme concen-
trations in the sera and several biological
features of the tumours. In tumours of
high immunogenicity and low metastatic
capacity, such as the HSBPA, high levels
of lysozyme are encountered (as high as
5 times the normal level) whereas in a
tumour of lower immunogenicity and high
metastatic capacity (i.e. the MC3) there
were minimal rises in lysozyme activity in
the sera. The HSN sarcoma which is
intermediate in both immunogenicity and
tendency to metastasize produced only a
moderate rise in lysozyme activity. An
examination of the lysozyme activity in
the lymph of tumour bearing animals and
in supernatant media of cultured cells
obtained from a growing tumour indicates
that the rise in serum lysozyme can be
attributed to its production and release by
host macrophages resident in the tumour
and in the regional lymph nodes. Eccles
and Alexander (1974) have already shown
that the macrophage content of tumours
is a reflection of a host immunological
response to the tumour and that there is
an inverse relationship between macro-
phage content and the development of
O - - IDp ECDG I
30
0)20
GD :3
E
' 1
N
0 n
E2, lo
0
0 5
57
-t%58 G. A. CURRIE AND S. A. ECCLES
metastases. They also indicated that
irradiation of the host rats leads to a fall
in tumour macrophage content and an
increased propensity to metastasize. A
similar irradiation protocol completely
abolished the rise in serum lysozyme
activity normally induced by the growth
of HSBPA in syngeneic rats. Subse-
quent amputation of the tumour in such
irradiated rats led to the rapid develop-
ment of massive widespread fatal metas-
tases. Assays of serial serum samples
from such rats indicated that the lysozyme
levels rose rapidly following amputation
and acted in this particular tumour as a
marker for the development ofmetastases.
The metastatic lesions themselves con-
tainedsubstantialnumbers ofmacrophages
(c. 30%) although this was lower than
the macrophage content of primary
HSBPA tumour growing in normal rats.
In such normal rats metastases did not
develop following amputation of the
HSBPA sarcoma and the serum lysozyme
levels showed no significant changes.
Perri and his colleagues (Perri et al.,
1963) have examined the concentration of
lysozyme in the kidneys of rats bearing
Jensen sarcoma allografts. They demon-
strated a massive rise in lysozyme activity
with progressive tumour growth and a
rapid decline following tumour excision.
In normal animals they showed that
splenectomy caused a substantial fall in
lysozyme activity, an observation which
suggested that the spleen was a major
site of lysozyme production. However,
in tumour bearing rats, splenectomy had
much less effect on lysozyme levels, a
finding which suggests that the tumour
associated rise in lysozyme was due to
increased enzyme production in sites
other than the spleen. Unfortunately,
they did not examine the tumour itself
for lysozyme content.
As the rate of lysozyme synthesis and
release by macrophages (and monocytes)
is unaffected by activation, the elevation
in lysozyme levels consequent upon the
growth of antigenic tumours (and BCG or
C. parvum) may be a reflection of an
increase in the number of macrophages in
the animal rather than any qualitative
change in their functional state. The
production and release of lysozyme by
macrophages resident in a tumour and in
the regional lymph nodes imply that
under well defined conditions, in the
absence of infectious processes and with
normal renal function, assays ofthe serum
levels of this enzyme may reflect macro-
phage mediated host responses to the
tumour. Although lysozyme is unlikely
tobea useful markerfortheearlydetection
and monitoring of tumours, it would
conceivably be of value in classification
and staging.
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